Francisco Guarner

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Randomized Controlled Trial

Infectious Diseases

Saccharomyces Cerevisiae

Top Venues

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy (2024)
Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy 41 (3) (2024)
Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy 41 (3) (2024)
Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy 41 (3) (2024)
Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy 41 (3) (2024)
Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy 41 (3) (2024)
Claudia Barber, Carlos Sabater, María Ángeles Ávila-Gálvez, Fernando Vallejo, Rogger Alvaro Bendezu, Laetitia Guérin-Deremaux, Francisco Guarner, Juan Carlos Espín, Abelardo Margolles, Fernando Azpiroz
Effect of Resistant Dextrin on Intestinal Gas Homeostasis and Microbiota. Nutrients 14 (21) (2022)
Claudia Barber, Marianela Mego, Carlos Sabater, Fernando Vallejo, Rogger Alvaro Bendezu, Marcela Masihy, Francisco Guarner, Juan Carlos Espín, Abelardo Margolles, Fernando Azpiroz
Differential Effects of Western and Mediterranean-Type Diets on Gut Microbiota: A Metagenomics and Metabolomics Approach. Nutrients 13 (8) (2021)
Franka Neumer, Orenci Urraca, Joaquin Alonso, Jesús Palencia, Vicente Varea, Stephan Theis, Maria Rodriguez-Palmero, José Antonio Moreno-Muñoz, Francisco Guarner, Gigi Veereman, Badriul Hegar, Cristina Campoy
Long-Term Safety and Efficacy of Prebiotic Enriched Infant Formula-A Randomized Controlled Trial. Nutrients 13 (4) (2021)